Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence

Biological Psychiatry

Volumn 55, Issue 3, 2004, Pages 255-262

  Bencherif, Badreddine ^a   Wand, Gary S ^a   McCaul, Mary E ^a   Kim, Yu Kyeong ^a   Ilgin, Nese ^a   Dannals, Robert F ^a   Frost, James J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; Craving; Depression; Mu opioid receptors; PET imaging

Indexed keywords

BRAIN RECEPTOR; CARBON 11; CARFENTANIL; MU OPIATE RECEPTOR;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BINDING ASSAY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; MALE; MOOD; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; SELF REPORT; SYMPTOM; WITHDRAWAL SYNDROME;

EID: 1642482761     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.07.007     Document Type: Article

References (64)

1. Altshuler H.L., Phillips P.E., Feinhandler D.A. Alteration of ethanol self-administration by naltrexone. Life Sci. 26:1980;679-688.
2. Anton R.F. Neurobehavioral basis for the pharmacotherapy of alcoholism Current and future directions . Alcohol Alcohol Suppl. 1:1996;43-53.
3. Anton R.F., Moak D.H., Latham P.K. The obsessive-compulsive drinking scale A new method of assessing outcome in alcoholism treatment studies . Arch Gen Psychiatry. 53:1996;225-231.
4. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;681-689.
5. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck 25 years of evaluation . Clin Psychol Rev. 8:1988;77-100.
6. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 91:1999;127-139.
7. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy Preliminary findings . Arch Gen Psychiatry. 58:2001;631-640.
8. Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., et al. A new, semi-structured psychiatric interview for use in genetic linkage studies A report on the reliability of the SSAGA . J Stud Alcohol. 55:1994;149-158.
9. Childress A.R., Ehrman R., McLellan A.T., MacRae J., Natale M., O'Brien C.P. Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat. 11:1994;17-23.
10. Cowen M.S., Lawrence A.J. Alterations in central preproenkephalin mRNA expression after chronic free-choice ethanol consumption by fawn-hooded rats. Alcohol Clin Exp Res. 25:2001;1126-1133.
11. Czirr S.A., Hubbell C.L., Reid L.D. Daily water deprivation potentiates ethanol intake beyond a period of water intake. Alcohol. 4:1987;117-120.
12. Derogatis L.D. SCL-90R. Administration, Scoring and Procedures Manual. 2nd ed :1987;Clinical Psychometric Research, Baltimore.
13. Desoto C.B., O'Donnell W.E., Allred L.J., Lopes C.E. Symptomology in alcoholics at various stages of abstinence. Alcohol Clin Exp Res. 9:1985;505-512.
14. Drobes D.J., Anton R.F., Thomas S.E., Voronin K. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption Naltrexone and nalmefene . Neuropsychopharmacology. 28:2003;755-764.
15. Flannery B.A., Volpicelli J.R., Pettinati H.M. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res. 23:1999;1289-1295.
16. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging A general linear approach . Hum Brain Mapp. 2:1995;189-210.
17. Froehlich J.C., Harts J., Lumeng L., Li T.K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav. 35:1990;385-390.
18. Froehlich J.C., Zweifel M., Hans J., Lumeng L., Li T.-K. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharm. 103:1995;467-472.
19. George M.S., Anton R.F., Bloomer C., Teneback C., Drobes D.J., Lorberbaum J.P., et al. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry. 58:2001;345-352.
20. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur J Pharm. 180:1990;21-29.
21. Gianoulakis C., Chan J.S., Kalant H., Chretien M. Chronic ethanol treatment alters the biosynthesis of beta-endorphin by the rat neurointermediate lobe. Can J Physiol Pharmacol. 61:1983;967-976.
22. Grant S., London E.D., Newlin D.B., Villemagne V.L., Liu X., Contoreggi C., et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A. 93:1996;12040-12045.
23. Hubbell C.L., Czirr S.A., Hunter G.A., Beaman C.M., LeCann N.C., Reid L.D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 3:1986;39-54.
24. Hubbell C.L., Marglin S.H., Spitalnic S.J., Abelson M.L., Wild K.D., Reid L.D. Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol. 8:1991;355-367.
25. Kiefer F., Horntrich M., Jahn H., Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharm. 162:2002;433-437.
26. Kornet M., Goosen C., Van Ree J.M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharm. 104:1991;367-376.
27. Kranzler H.R., Anton R.F. Implications of recent neuropharmacologic research for understanding etiology and development of alcoholism. J Consult Clin Psychol. 62:1994;1116-1126.
28. Krishnan-Sarin S., Jing S.L., Kurtz D.L., Zweifel M., Portoghese P.S., Li T.-K., Froehlich J.C. The delta opioid receptor antagonist naltrindole attentuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharm. 120:1995;177-185.
29. Krishnan-Sarin S., Portoghese P.S., Li T.-K., Froehlich J.C. The delta opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav. 52:1995;153-159.
30. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., Rosenheck R.A. Naltrexone in the treatment of alcohol dependence. N Engl J Med. 345:2001;1734-1739.
31. Li X., Li T.K., Froehlich J.C. Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference. Brain Res. 794:1998;35-47.
32. Linseman M.A., Harding S. Intracerebroventricular morphine enhances alcohol consumption by rats. Pharmacol Biochem Behav. 36:1990;405-408.
33. Litt M.D., Cooney N.L., Kadden R.M., Gaupp L. Reactivity to alcohol cues and induced moods in alcoholics. Addictive Behav. 15:1990;137-146.
34. Maas L.C., Lukas S.E., Kaufman J.J., Weiss R.D., Daniels S.L., Rogers V.W., et al. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 155:1998;124-126.
35. Mangold DL, Peyrot M, Giggey P, Wand GS (2000 Jun): Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism. Neuropsychopharmacology. 22:595-607.
36. Mann K., Agartz I., Harper C., Shoaf S., Rawlings R.R., Momenan R., Hommer D.W. Neuroimaging in alcoholism Ethanol and brain damage . Alcohol Clin Exp Res. 25:2001;104S-109S.
37. Marfaing-Jallat P., Miceli D., LeMagnen J. Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav. 18:(suppl 1):1983;537-539.
38. Marlatt G.A., Gordon J.R. Relapse Prevention. 1983;Guilford Press, New York.
39. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood Converging PET findings in depression and normal sadness . Am J Psychiatry. 156:1999;675-682.
40. McCaul M.E., Wand G.S., Eissenberg T., Rohde C.A., Cheskin L.J. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology. 22:2000;480-492.
41. McNair D.M., Lorr M., Droppleman L.F. EdITS manual of the Profile of Mood States. 1992;EdITS/Educational and Industrial Testing Service, San Diego, CA.
42. Mercier C, Brochu S, Girard M, Gravel J, Ouellet R, Pare R (1992): Profiles of alcoholics according to the SCL-90-R: A confirmative study. Int J Addict 27:1267-82.
43. Moak D.H., Anton R.F., Latham P.K. Further validation of the Obsessive-Compulsive Drinking Scale. Am J Addict. 7:1998;14-23.
44. Modell J.G., Glaser F.B., Mountz J.M. Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcoholism: Clin Exp Res. 16:1992;266-271.
45. Myers R.D., Borg S., Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 3:1986;383-388.
46. O'Brien C.P., Volpicelli L.A., Volpicelli J.R. Naltrexone in the treatment of alcoholism A clinical review . Alcohol. 13:1996;35-39.
47. O'Malley S.S. Opioid antagonists in the treatment of alcohol dependence Clinical efficacy and prevention of relapse . Alcohol Alcohol Suppl. 1:1996;77-81.
48. O'Malley S.S., Krishnan-Sarin S., Farren C., O'Connor P.G. Naltrexone-induced nausea in patients treated for alcohol dependence Clinical predictors and evidence for opioid-mediated effects . J Clin Psychopharmacol. 20:2000;69-76.
49. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., Kreek J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology. 160:2002;19-29.
50. Reid L.D., Czirr S.A., Bensinger C.C., Hubbell C.L., Volanth A.J. Morphine and deprenorphine together potentiate intake of alcoholic beverages. Alcohol. 4:1987;161-168.
51. Reid L.D., Delconte J.D., Nichols M.L., Bilsky E.J., Hubbell C.L. Tests of opioid deficiency hypotheses of alcoholism. Alcohol. 8:1991;247-257.
52. Roberts J.S., Anton R.F., Latham P.K., Moak D.H. Factor structure and predictive validity of the Obsessive-Compulsive Drinking Scale. Alcohol Clin Exp Res. 23:1999;1484-1491.
53. Samson H.H., Doyle T.F. Oral ethanol self-administration in the rat Effect of naloxone . Pharmacol Biochem Behav. 22:1985;91-100.
54. Schulz R., Wuster M., Duka T., Herz A. Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharm. 68:1980;221-227.
55. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar) . Br J Addict. 84:1989;1353-1357.
56. Swift R.M., Whelihan W., Kuznetsov O. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry. 151:1994;1463-1467.
57. Tiffany S.T. A cognitive model of drug urges and drug-use behavior The role of automatic and non-automatic processes . Psychol Rev. 97:1990;147-168.
58. Volkow N.D., Fowler J.S., Wolf A.P., Hitzemann R., Dewey S., Bendriem B., et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 148:1991;621-626.
59. Volpicelli J., David M.A., Olgin J.E. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci. 38:1986;841-847.
60. Wand G.S., Mangold D., Ali M., Giggey P. Adrenal cortisol responses and family history of alcoholism. Alcohol Clin Exp Res. 23:1999;1185-1190.
61. Wand GS, Mangold D, El Diery S, McCaul M, Hoover D (1998): Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychiatry 1114-1119.
62. Wand G.S., McCaul M., Gotjen D., Reynolds J., Lee S. Confirmation that offspring from families with alcohol dependent individuals have greater HPA axis activation induced by naloxone compared to offspring without a family history of alcohol dependence. Alcohol Clin Exp Res. 25:2001;1134-1139.
63. Weiss F., Mitchiner M., Bloom F.E., Koob G.F. Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharm. 101:1990;178-186.
64. Whalen P.J., Shin L.M., Somerville L.H., McLean A.A., Kim H. Functional neuroimaging studies of the amygdala in depression. Semin Clin Neuropsychiatry. 7:2002;234-242.